Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
2019 Life Science Innovation Northwest - Schedule
Share |

Explore your options to connect, learn, and be inspired at the 2019 Life Science Innovation Conference. New panelists and speakers are being added often… check back for updates.






CONFERENCE HIGHLIGHTS



DAY 1: WEDNESDAY, APRIL 24, 2019


 PANELIST/SPEAKER 
Life Science Innovation Northwest - Keynote Speaker - Roger Perlmutter MD, PhD

Keynote Address:
Roger M. Perlmutter, MD, PhD

Executive Vice President and President, Merck Research Laboratories

  • Executive vice president and president, Merck Research Laboratories, 2013
  • Executive vice president and head of Research and Development, Amgen Inc., 2001-2012
  • Executive vice president of Worldwide Basic Research and Preclinical Development, Merck Research Laboratories, 1998-2001; senior vice president, Merck Research Laboratories, 1997-1998
  • Professor, Departments of Immunology, Biochemistry and Medicine, University of Washington, 1991-1997

PANEL: NEXT FRONTIERS IN CELLULAR IMMUNOTHERAPY

This panel will address the latest developments in CAR-T therapy, the challenges associated with using CAR-T therapy with new tumor targets, and new types of cellular immunotherapies that are now coming into play.


Panel Chair: James N. Topper, MD, PhD, Managing General Partner, Frazier Healthcare Partners


Colleen Delaney, MD, MSc, Founder and Chief Scientific Officer, Executive Vice President of Research and Development, Nohla Therapeutics


Peter C.R. Emtage, PhD, Senior Vice President and Global Head of Cell Therapy Research, KitePharma , a Gilead company


Robert Hershberg, MD, PhD,Executive Vice President, Head of Business Development and Global Alliances, Celgene Corporation


Stanley Riddell, MD, Scientific Director, Immunotherapy Integrated Research Center, Fred Hutch


 

PANEL: FEDERAL POLICY


Coming Soon
 

PANEL: OPPORTUNITIES AND CHALLENGES IN GENE EDITING


Panel Chair: Jerel Davis, Managing Director, Versant Ventures


Stacy Coen, Vice President Of Business Development, Editas Medicine


Philip D. Gregory, DPhil, Chief Scientific Officer, Bluebird Bio


Ruwanthi (Ru) Gunawardane, PhD, Director, Stem Cells & Gene Editing, Allen Institute for Cell Science


Andrew M. Scharenberg, MD, Chief Scientific Officer, Casebia Therapeutics

 

PANEL: ISSUES AND TRENDS IN VENTURE INVESTING

Veteran biotech commentator Karen Bernstein will explore themes in current venture investing with a panel of active venture investors.


Panel Chair: Karen Bernstein,
Chairman, BioCentury


Carol Gallagher, Partner, New Enterprise Associates


Nina Kjellson, General Partner, Canaan


KT Moortgat, PhD, Director, West Coast, AbbVie Ventures


Andrew J. Schwab, Founder and Managing Partner, 5AM Ventures


Peter Thompson, MD, Partner, OrbiMed Healthcare Fund Management

 

COMPANY PODIUM PRESENTATIONS

Podium Presentations are the perfect way to increase visibility for your company and attract strategic partners at LSINW. Pitch your company’s story, pipelines, and objectives! Apply here.


Individual Company Presentations
   

DAY 2: THURSDAY, APRIL 25, 2019


 PANELIST/SPEAKER
 

FIRESIDE CHAT: NEW HORIZONS FOR DESIGN OF PROTEIN-BASED THERAPEUTICS

David Baker, PhD, is the Henrietta and Aubrey Davis Endowed Professor in Biochemistry, Director of the Institute for Protein Design, Investigator of the Howard Hughes Medical Institute, and adjunct professor of Genome Sciences, Bioengineering, Chemical Engineering, Computer Science, and Physics at the University of Washington.


Professor David Baker, PhD


Interviewer: Simone Fishburn, PhD, Vice President and Executive Editor, BioCentury.

 

PANEL: EARLY STAGE COMPANIES

A panel of selected seed-stage companies will briefly present their stories and will then discuss stage, impact, strategy and development.


Coming Soon
 

PANEL: CURRENT TRENDS IN MEDICAL DEVICE INVESTING


Panel Chair: David Cassak, Managing Partner of Innovation in Medtech LLC

Trevor Moody, Partner - Medical Devices, M.H. Carnegie & CO


Jens Quistgaard, President & CEO, Taproot Medical Technologies


Additional panelists pending

 

PANEL: LESSONS LEARNED IN ANGEL INVESTING


Panel Chair: Richard Samuelson, Independent life science investor


Carla Fowler, AoA


Keiretsu Forum, Seattle


Jim Reed, SWAN


Bill Waller, WINGS


 

FAST PITCH - SEED COMPANIES

A series of 1- minute pitches by early stage companies.The best pitch receives $5,000 cash prize. 


Individual Company Presentations 

 

PANEL: The C-SATS Story: Building a Successful Digital Health Venture


Panel Chair: Fiona Wills, Assistant Vice President, Innovation Development, UW CoMotion


Eric Bell, Managing Director, SpringRock Ventures


Thomas S. Lendvay, MD FACS, Profoessr, Dept of Urology, UW; Director, Robotic Surgery Center, Seattle Children’s Hospital, CSATS Co-Founder and Former CMO


Loretta Little, Managing Director, WRF Capital


Derek Streat, VP of Digital Education Solutions, Johnson & Johnson Institute, Co-Founder & CEO, C-SATS





more Calendar

2/21/2019
Life Science Industry Networking Event - February

2/26/2019
Intensive SBIR/STTR Workshop: NIH Focus- Spokane

Featured Member
BioTech Primer Inc.BioTech Primer develops and delivers customized training to the Life Sciences community

Membership Management Software Powered by YourMembership  ::  Legal